Clinical trial
Biomarker Discovery for Suicide Precision Circuit Therapeutics
NCT07723066 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Discovery for Suicide Precision Circuit Therapeutics
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- August 31, 2030
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
major depressive episode (mde), suicidal thoughts and behaviors